IIT2020-20-SHIRAZIP-WALK: Nature Walks

NCT04896580 | Completed

• 1 other identifier: STUDY00001356
• Study Type: interventional
• Target: 20
• Locations: 1 country
• Sites: 1

Brief Summary

The purpose of this study is to examine whether nature-based activities provide benefits for breast cancer survivors. The investigators want to know whether a nature-based exercise program is feasible. Women who were diagnosed with breast cancer and have completed cancer treatment will be recruited for the main study. The main study will enroll up to 20 breast cancer subjects in total. This intervention will also include a sub-study examining the same outcomes among adolescents and young adult (AYA) subjects who were diagnosed with cancer (any type) and have completed cancer treatment. The sub-study will enroll up to 20 AYA (ages 18-39) subjects.

Conditions

Breast Cancer; Cancer; Lymphoma; Leukemia; Prostate Cancer; Thyroid Cancer; Hematologic Malignancy; Non-hodgkin Lymphoma

Keywords

Nature; Exercise; Walking; Psychosocial Well-Being

Outcome Measures

Primary Outcomes (1)

• Number of participants that adhere to a 3-month nature-based walking program

  Feasibility of Nature Walk Programs

  12 weeks

Secondary Outcomes (12)

• Short-term effects of green space and nature physical activity environments on well-being

  Measured at Baseline and at Week 12

• Short-term effects of green space and nature physical activity environments on social well-being

  Measured at Baseline and at Week 12

• Short-term effects of green space and nature physical activity environments on post-trauma growth and self-improvement

  Measured at Baseline and at Week 12

• Short-term effects of green space and nature physical activity environments on physical, social/family, emotional, and functional well-being

  Measured at Baseline and at Week 12

• Biologic aging markers

  Measured at Baseline and at Week 12

Study Arms (1)

Active

EXPERIMENTAL

Participants will be asked to complete a 12 week exercise program

Behavioral: Nature based exercise

Interventions

Nature based exercise BEHAVIORAL

Participants will engage in three months of moderate intensity PA, consisting of three 50-minute walking sessions per week (5-minute warm-up, 40 minute walk, 5 minute cool-down and stretch) with an exercise physiologist for 12 weeks.

Active

Eligibility Criteria

• Age: 18 Years+
• Sex: female
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Female previously diagnosed with breast cancer (clinical stages 1 - 3)
• Minimum of 3 months post-active treatment completion
• Maximum of 21 months post-active treatment completion
• Physically able to complete baseline fitness assessments (e.g., 6-minute walk test, hand grip test, 1 RM leg press)
• Ambulatory without assistance

You may not qualify if:

• Active treatment planned within the next 6 months.
• Known metastatic disease.
• Currently meeting physical activity guidelines (score of \>23 on Godin-Shephard Leisure-Time Physical Activity Questionnaire).
• Known allergy to Fitbit device or otherwise unable to wear Fitbit device.
• Men and women between age of 18 to 39
• Previously diagnosed with cancer
• Below 18 years old
• Above 39 years old

Sponsors & Collaborators

• Cedars-Sinai Medical Center: lead

Study Sites (1)

Cedars-Sinai Medical Center

Los Angeles, California, 90069, United States

Location

Related Publications (1)

• Shirazipour CH, Raines C, Liu E, Ruggieri RM, Capaldi JM, Luna-Lupercio B, Diniz MA, Gresham G, Bhowmick N, Haile RW, Asher A. Benefits of nature-based walking for breast cancer survivors. BMJ Open. 2023 Jun 16;13(6):e071041. doi: 10.1136/bmjopen-2022-071041.

  PMID: 37328178 DERIVED

MeSH Terms

Conditions

Breast Neoplasms; Neoplasms; Lymphoma; Leukemia; Prostatic Neoplasms; Thyroid Neoplasms; Hematologic Neoplasms; Lymphoma, Non-Hodgkin; Motor Activity

Condition Hierarchy (Ancestors)

Neoplasms by Site; Breast Diseases; Skin Diseases; Skin and Connective Tissue Diseases; Neoplasms by Histologic Type; Lymphoproliferative Disorders; Lymphatic Diseases; Hemic and Lymphatic Diseases; Immunoproliferative Disorders; Immune System Diseases; Hematologic Diseases; Genital Neoplasms, Male; Urogenital Neoplasms; Genital Diseases, Male; Genital Diseases; Urogenital Diseases; Prostatic Diseases; Male Urogenital Diseases; Endocrine Gland Neoplasms; Head and Neck Neoplasms; Endocrine System Diseases; Thyroid Diseases; Behavior

Study Officials

• Celina Shirazipour, PhD

  Cedars-Sinai Medical Center

  PRINCIPAL INVESTIGATOR

• Arash Asher, M.D.

  Cedars-Sinai Medical Center

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: SUPPORTIVE CARE
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Assistant Professor, Cedars-Sinai Cancer Research Center for Health Equity

Study Record Dates

• First Submitted: April 19, 2021
• First Posted: May 21, 2021
• Study Start: June 21, 2021
• Primary Completion: May 18, 2023
• Study Completion: May 18, 2023
• Last Updated: February 26, 2025

Record last verified: 2025-02

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)